Fisher & Paykel Healthcare Corporation Limited advises that all resolutions put to the company’s annual shareholders’ meeting held today were passed. The five resolutions were:

Resolution 1: To re-elect Sir Michael Daniell as a Director.
Resolution 2: To elect Graham McLean as a Director.
Resolution 3: To authorise the Directors to fix the fees and expenses of the company’s auditor.
Resolution 4: To approve the issue of performance share rights to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2024.
Resolution 5: To approve the issue of options to Lewis Gradon as set out in the Notice of Annual Shareholders’ Meeting 2024.


All resolutions were decided by poll. The details of the total number of votes cast online, in person or by proxy on the polls were as follows:
 

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Contacts:

Media Karen Knott GM Corporate Communications karen.knott@fphcare.co.nz +64 21 713 911   Investors Dan Adolph Head of Investor Relations daniel.adolph@fphcare.co.nz +64 22 511 4050

Authorised by Raelene Leonard, General Counsel and Company Secretary.